MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0012744
Stafford Laboratories Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹33.42 Cr
▲ 14% YoY
Net profit · FY 2024
₹95.58 Lakh
Net margin 2.9%
EBITDA · FY 2024
₹2.16 Cr
EBITDA margin 6.5%
Authorised capital
₹1.2 Cr
Registered with MCA
Paid-up capital
₹1.1 Cr
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹6.67 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
30
Provident fund records
About Stafford Laboratories Private Limited
Data last updated:
Stafford Laboratories Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1999PTC089423. Its GSTIN is 05AAGCS5386Q1ZK (Uttarakhand).
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.1 Cr. It is led by directors including Debi Datta and Raj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2A Sir Deva Prasad Rowgr Floor, Kolkata, West Bengal, India – 700014.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.42 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹95.58 Lakh (net margin 2.9%) and EBITDA of ₹2.16 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 20% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹6.67 Cr on record. Court records list 14 cases involving the company, including 2 filed by the company and 12 filed against it; 9 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70.4 Lakh; the latest was in March 2017. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Franco-Indian Remedies Private Limited with revenue of ₹33.65 Cr.
Stafford Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0012744). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website staffordlaboratories.com.
Company details
CIN U24232WB1999PTC089423
Registration Number 089423
Incorporation Date 17 May 1999
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0012744
Recognitions & Rankings of Stafford Laboratories
Contact details
Stafford Laboratories Private Limited's registered office is in Kolkata, West Bengal. Its website is staffordlaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2A Sir Deva Prasad Rowgr Floor, Kolkata, West Bengal, India – 700014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stafford Laboratories Private Limited, buy the company report.
Comprehensive company report
Stafford Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Stafford Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stafford Laboratories Private Limited, buy the company report.
Financials of Stafford Laboratories Private Limited
FY 2024 filings availableStafford Laboratories Private Limited reported revenue of ₹33.42 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹33.42 Cr ▲ 14%
Net profit · FY 2024
₹95.58 Lakh margin 2.9%
EBITDA · FY 2024
₹2.16 Cr margin 6.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 28%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 35%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 14% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹33.42 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stafford Laboratories Private Limited, buy the company report.
Board of directors of Stafford Laboratories Private Limited
Stafford Laboratories has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Debi Datta Also directs: Stafford Health Care LLP, Pee Dee Pharma Pvt Ltd | Director | 17 May 1999 | 27 Years 5 Months | Current |
| Raj Kumar | Director | 02 May 2015 | 11 Years 6 Months | Current |
| Prasanta Datta Also directs: Pee Dee Pharma Pvt Ltd | Director | 17 May 1999 | 27 Years 5 Months | Current |
| Sunita Rani | Director | 03 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Stafford Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Franco-Indian Remedies Private Limited | ₹33.65 Cr (FY 2024) | -8.0% | Tamil Nadu, India | |||
| Kosher Pharmaceutical Private Limited | ₹33.59 Cr (FY 2020) | 135.0% | Hyderabad, Telangana, India | |||
| Cureza Healthcare Private Limited | ₹33.53 Cr (FY 2025) | 74.0% | Indore, Madhya Pradesh, India | |||
| Stafford Laboratories Private Limitedthis company | ₹33.42 Cr (FY 2024) | ₹95.58 Lakh | 2.9% | 14.0% | 30 | Kolkata, West Bengal, India |
| Pegasus Farmaco (India) Private Limited | ₹33.13 Cr (FY 2021) | -34.0% | Telangana, India | |||
| Kim Laboratories Pvt Ltd | ₹33.1 Cr (FY 2025) | 4.0% | Haryana, India |
To see the full peer comparison of Stafford Laboratories Private Limited, buy the company report.
Auditor
Stafford Laboratories Private Limited is audited by VK KHOSLA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VK KHOSLA & CO. | FY 2024 | 002283N |
Shareholding
The shareholding of Stafford Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stafford Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹6.67 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2023 | 100771252 | Dhanlaxmi Bank Limited | ₹2 Cr | Satisfied | |
| 30 Jun 2022 | 100600882 | Dhanlaxmi Bank Limited | ₹95 Lakh | Satisfied | |
| 27 Mar 2006 | 90370394 | Union Bank of India | ₹3.72 Cr | Satisfied |
To see the full charge records of Stafford Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Stafford Laboratories Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70.4 Lakh; the latest was in March 2017.
Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹70.4 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2012 | Funding round | ₹41 Lakh | Investors: 4 individuals |
| Jul 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹29.4 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stafford Laboratories Private Limited has 14 court cases on record: 2 filed by Stafford Laboratories, 12 filed against it. 9 cases are pending and 5 are disposed.
Total cases
14
Filed by the company
2
Filed against the company
12
Pending
9
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 9 | 6 |
| High courts | 4 | 3 | 3 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Commercial suit | Filed against the company by Johnlee Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Cedar Properties and Trading LLP & Ors. | Pending |
| District court, West, Delhi | Criminal case | Filed by the company against Big Laboratories Pvt Ltd and 1 other | Pending |
To see the full case history of Stafford Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stafford Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stafford Laboratories Private Limited has a workforce of 30 employees on its EPFO records as of Mar 27, 2025, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
7.14%
GST
Stafford Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGCS5386Q1ZK | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stafford Laboratories Private Limited, buy the company report.
Recent activity
Stafford Laboratories Private Limited has 12 board changes on record since 1999: 4 appointments and 8 cessations. The latest: Raj Kumar ceased to be Additional Director on 30 Sep 2022.
Charges
A charge registered on 01 Aug 2023 via Charge ID 100771252 with Dhanlaxmi Bank Limited was fully satisfied on 15 Apr 2025.
AGM
Stafford Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Stafford Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Charges
A charge with Dhanlaxmi Bank Limited of Rs. 2.00 Cr registered on 01 Aug 2023 with Charge ID 100771252 was modified on 05 Sep 2023.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100771252 was registered on 01 Aug 2023.
Charges
A charge registered on 30 Jun 2022 via Charge ID 100600882 with Dhanlaxmi Bank Limited was fully satisfied on 28 Jul 2023.
Ceased
Raj Kumar ceased to be Additional Director.
Ceased
Sunita Rani ceased to be Director Appointed In Casual Vacancy.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.95 Cr with Charge ID 100600882 was registered on 30 Jun 2022.
Appointed
Sunita Rani was appointed as Director.
Ceased
Shyam Lal ceased to be Additional Director.
Ceased
Arun Kumar ceased to be Additional Director.
11 earlier events are in the company report.
Frequently asked questions
Stafford Laboratories is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 1999 (27+ years old) and is registered under CIN U24232WB1999PTC089423.
Stafford Laboratories has 4 current directors:
- Debi Datta - Director
- Raj Kumar - Director
- Prasanta Datta - Director
- Sunita Rani - Director
The latest financial statements of Stafford Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stafford Laboratories is 05AAGCS5386Q1ZK, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Stafford Laboratories is U24232WB1999PTC089423. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stafford Laboratories has 14 court cases on record: 2 filed by the company and 12 filed against it. 9 are pending. Most are in the district courts.
Stafford Laboratories was incorporated on 17 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Kolkata.
Stafford Laboratories has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹70.4 Lakh; the latest was in March 2017.
The peers of Stafford Laboratories by revenue are Franco-Indian Remedies Private Limited, Kosher Pharmaceutical Private Limited, Cureza Healthcare Private Limited, Pegasus Farmaco (India) Private Limited, Kim Laboratories Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Raj Kumar ceased to be Additional Director on 30 Sep 2022. Sunita Rani ceased to be Director Appointed In Casual Vacancy on 30 Sep 2022. Sunita Rani was appointed as Director on 03 Aug 2020. Stafford Laboratories has 12 board changes on record in total.
Yes, Stafford Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0012744).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages